13F filer · CIK 1344551 ↗
Assetmark, Inc
You are looking at Q4 2017. See the latest, Q3 2026 →
Reported value
$9.70B
+10% on the quarter before
Positions
2,254
732 new · 75 sold out
Top 10
27.8%
of the value
Est. gain
+$269.3M
on stocks held all quarter
Est. return
+3.4%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Assetmark, Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr Msci Acwi ETF~$113.2MAdded · 0.0% → 1.2%+1,570,691 shares
- First Tr Exchange Traded Fd Dj Internt Idx~$69.2MAdded · 0.5% → 1.2%+629,854 shares
- Fqf Tr Oshars Ftse Us~$67.6MNew · 0.0% → 0.7%+2,118,418 shares
- SPDR Series Trust S&P Ins ETF~$66.2MAdded · 0.0% → 0.7%+2,156,150 shares
- Vanguard Index Fds S&P 500 ETF Shs~$49.9MAdded · 4.7% → 5.0%+203,487 shares
- Ishares Tr Iboxx Inv Cp ETF~$48.1MAdded · 0.6% → 1.0%+395,550 shares
- Ishares Tr U.S. Utilits ETF~$46.9MAdded · 0.7% → 1.1%+352,754 shares
- Ishares Tr Eafe Grwth ETF~$46.2MNew · 0.0% → 0.5%+572,102 shares
- Schwab Strategic Tr Us Tips ETF~$46.0MAdded · 0.1% → 0.5%+830,341 shares
- Powershares Qqq Trust Unit Ser 1~$45.1MAdded · 0.0% → 0.5%+289,553 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr Global Tech ETF~$111.0MCut · 1.2% → 0.0%−727,789 shares
- Ishares Tr Rus 1000 Grw ETF~$110.6MCut · 1.2% → 0.0%−826,554 shares
- Ishares Tr Us Home Cons ETF~$84.0MCut · 0.7% → 0.0%−1,679,644 shares
- Ishares Tr U.S. Fin Svc ETF~$62.4MCut · 0.7% → 0.0%−478,583 shares
- Vanguard Scottsdale Fds Shrt Trm Corp Bd~$50.5MCut · 0.9% → 0.3%−637,348 shares
- Ishares Tr Fltg Rate Nt ETF~$43.0MCut · 0.7% → 0.2%−846,602 shares
- Ishares Tr Gov/Cred Bd ETF~$42.5MCut · 0.5% → 0.0%−372,739 shares
- Ishares Tr Intrmd Cr Bd ETF~$37.8MCut · 2.0% → 1.4%−345,838 shares
- SPDR Series Trust S&P Biotech~$37.3MCut · 1.2% → 0.7%−439,773 shares
- Ishares Tr Core Div Grwth~$24.2MCut · 0.3% → 0.0%−709,301 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vanguard Index Fds S&P 500 ETF ShsETF · shares +11% · price +6.3% | 5.0% | $486.5M | +$25.9M | ||||||||
| SPDR Series Trust Bloomberg BrclysETF · shares +14% · price −1.6% | 3.5% | $339.1M | −$4.9M | ||||||||
| Ishares Tr Iboxx Hi Yd ETFETF · shares +11% · price −1.7% | 3.4% | $327.7M | −$5.1M | ||||||||
| SPDR S&P 500 ETF Tr Tr UnitETF · shares +8.7% · price +6.2% | 3.3% | $320.2M | +$17.3M | ||||||||
| Vanguard Index Fds Value ETFETF · shares −3.8% · price +6.5% | 2.5% | $238.9M | +$14.6M | ||||||||
| Ishares Tr Core Msci EafeETF · shares +18% · price +3.0% | 2.4% | $234.0M | +$5.7M | ||||||||
| Vanguard Index Fds Growth ETFETF · shares +4.7% · price +6.0% | 2.0% | $198.9M | +$10.7M | ||||||||
| Ishares Inc Core Msci EmktETF · shares +13% · price +5.3% | 2.0% | $196.9M | +$8.8M | ||||||||
| Vanguard Tax Managed Intl Fd Ftse Dev Mkt ETFETF · shares +7.0% · price +3.4% | 1.9% | $182.9M | +$5.5M | ||||||||
| Vanguard World Fd Mega Cap Val ETFETF · shares +7.0% · price +6.5% | 1.8% | $175.4M | +$10.0M | ||||||||
| Vanguard World Fd Mega Grwth IndETF · shares +7.0% · price +6.3% | 1.6% | $155.9M | +$8.7M | ||||||||
| Ishares Tr Intrmd Cr Bd ETFETF · shares −21% · price −0.9% | 1.4% | $137.9M | −$1.2M | ||||||||
| SPDR Index Shs Fds Portfolio DevlpdETF · shares −1.9% · price +3.4% | 1.4% | $135.2M | +$4.4M | ||||||||
| Vanguard Bd Index Fd Inc Total Bnd MrktETF · shares +16% · price −0.5% | 1.3% | $128.4M | −$531,212 | ||||||||
| Vanguard Index Fds Sm Cp Val ETFETF · shares +11% · price +3.9% | 1.2% | $120.5M | +$4.1M | ||||||||
| Ishares Tr India 50 ETFETF · shares +1.6% · price +8.9% | 1.2% | $115.8M | +$9.3M | ||||||||
| Ishares Tr Phlx Semicnd ETFETF · shares +1.6% · price +7.1% | 1.2% | $115.7M | +$7.5M | ||||||||
| First Tr Exchange Traded Fd Dj Internt IdxETF · shares +149% · price +7.3% | 1.2% | $115.7M | +$3.2M | ||||||||
| Ishares Tr U.S. Med Dvc ETFETF · shares +4.6% · price +3.9% | 1.2% | $114.2M | +$4.1M | ||||||||
| Ishares Tr Msci Acwi ETFETF · shares +209,705% · price +3.8% | 1.2% | $113.3M | +$1,995 | ||||||||
| Vanguard Index Fds Sml Cp Grw ETFETF · shares +5.9% · price +5.4% | 1.2% | $112.5M | +$5.4M | ||||||||
| Ishares Tr Core Msci EuroETF · shares +8.8% · price +1.0% | 1.1% | $109.3M | +$981,283 | ||||||||
| Ishares Tr U.S. Utilits ETFETF · shares +78% · price −0.0% | 1.1% | $106.9M | −$17,526 | ||||||||
| Ishares Tr Iboxx Inv Cp ETFETF · shares +90% · price +0.3% | 1.0% | $101.8M | +$145,935 | ||||||||
| Ishares Tr 20 Yr Tr Bd ETFETF · shares −2.9% · price +1.7% | 1.0% | $101.6M | +$1.7M | ||||||||
| Total · 2,254 positions | 100% | $9.70B | +$269.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 1,369 stocks held throughout, up $269.3M (+3.4%).
- Vanguard Index Fds S&P 500 ETF Shs+$25.9M+6%
- SPDR S&P 500 ETF Tr Tr Unit+$17.3M+6%
- Vanguard Index Fds Value ETF+$14.6M+7%
- Vanguard Index Fds Growth ETF+$10.7M+6%
- Vanguard World Fd Mega Cap Val ETF+$10.0M+7%
- Ishares Tr Intrmd Cr Bd ETF−$1.2M−1%
- SPDR Series Trust S&P Biotech−$1.4M−2%
- Gilead Sciences Inc Com−$4.2M−12%
- SPDR Series Trust Bloomberg Brclys−$4.9M−2%
- Ishares Tr Iboxx Hi Yd ETF−$5.1M−2%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 9 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $59.48B+2% | SEC ↗ |
| Q2 2026 | Jul 30, 2026 | $58.17B+19% | SEC ↗ |
| Q1 2026 | May 6, 2026 | $49.04B+0% | SEC ↗ |
| Q4 2025 | Jan 23, 2026 | $49.04B+5% | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | $46.65B+10% | SEC ↗ |
| Q2 2025 | Aug 4, 2025 | $42.36B+16% | SEC ↗ |
| Q1 2025 | May 6, 2025 | $36.41B−1% | SEC ↗ |
| Q4 2024 | Feb 6, 2025 | $36.81B+5% | SEC ↗ |
| Q3 2024 | Nov 1, 2024 | $34.92B+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $32.33B+5% | SEC ↗ |
| Q1 2024 | May 7, 2024 | $30.76B+11% | SEC ↗ |
| Q4 2023 | Feb 9, 2024 | $27.67B+11% | SEC ↗ |
| Q3 2023 | Oct 27, 2023 | $25.01B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $25.49B+5% | SEC ↗ |
| Q1 2023 | May 5, 2023 | $24.19B+5% | SEC ↗ |
| Q4 2022 | Feb 10, 2023 | $23.07B+8% | SEC ↗ |
| Q3 2022 | Nov 1, 2022 | $21.39B−4% | SEC ↗ |
| Q2 2022 | Aug 3, 2022 | $22.31B−7% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $23.89B−2% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $24.34B+9% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $22.32B+4% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $21.56B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $19.39B+8% | SEC ↗ |
| Q4 2020 | Feb 10, 2021 | $17.95B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $15.50B+11% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $13.98B+18% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $11.81B−10% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $13.16B+10% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $11.95B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $12.27B+11% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $11.07B+7% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $10.36B−6% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $11.00B+8% | SEC ↗ |
| Q2 2018 | Aug 1, 2018 | $10.18B+5% | SEC ↗ |
| Q1 2018 | May 16, 2018 | $9.66B−0% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $9.70B+10% | SEC ↗ |
| Q3 2017 | Nov 8, 2017 | $8.79B+11% | SEC ↗ |
| Q2 2017 | Aug 15, 2017 | $7.95B+4% | SEC ↗ |
| Q1 2017 | Sep 15, 2017 (amended) | $7.61B+12% | SEC ↗ |
| Q4 2016 | Sep 15, 2017 (amended) | $6.81B+4% | SEC ↗ |
| Q3 2016 | Sep 15, 2017 (amended) | $6.58B+11% | SEC ↗ |
| Q2 2016 | Sep 15, 2017 (amended) | $5.95B+4% | SEC ↗ |
| Q1 2016 | Sep 15, 2017 (amended) | $5.73B | SEC ↗ |